Okay

... um, but there's caveat, right? Leukocytosis can also be stress and other reasons, too.

So just keeping an eye on, like, is it ba- um, neutrophil predominant? Is there bandemia? A lot of times i- in the ID world, we love to look at CBC with differentials.

You know, bands is a clue.

You know, procal not so much, but bandemia is giving me more concern.

So, like, those lab.

But clinical features.

So what's one principle that you wish every team understood about managing a pleural space infection?

What's going on through your head about microbiology, antibiotic selection, and things like that?

Great question.

So I always think about, like, is it loculated fluid, is it empyema? And a lot of times definitely sending for aerobic and anaerobic cultures are gonna be important, so I keep an eye on those.

And we go, you know, talk with the microbiology team and making sure, like, what do you see, right? So those are the work that we are doing behind.

But for myself, um, you know, I always teach my fellows it's really important to cover for anaerobes too.

So a lot of times, okay, MRSA is growing, we're just gonna focus on MRSA, but you all know when you drain the fluid, put it on a Petri dish, you're exposing it to air, a lot of times you're gonna g- anaerobes are not gonna grow.

So I make sure that we're covering if it's loculated, complicated, you're covering for the organism, but also for anaerobes.

So what's one principle that you wish every team understood about managing a pleural space infection?